Skip to main content
. 2021 Sep 12;2021(9):CD011612. doi: 10.1002/14651858.CD011612.pub3

NCT04399070.

Study name The Effect of S‐ketamine for Patients Undergoing Electroconvulsive Therapy (ECT) (ECT)
Methods RCT
Participants
  • American Society of Anesthesiologists (ASA) Physical Status I‐II

  • diagnose depressive disorders with DSM‐IV

  • Without cognitive impairment

  • Without ECT in past 6 months

Interventions Placebo Comparator: Propofol group
patients were treated with propofol 1 mg/kg and saline bolus infusion before ECT
Active Comparator: Ketamine group
patients were treated with propofol 1 mg/kg and ketamine 0.5 mg/kg bolus infusion before ECT
Experimental: S‐ketamine group
patients were treated with propofol 1 mg/kg and S‐ketamine 0.25 mg/kg bolus infusion before ECT
Outcomes
  1. Hamilton Depression Scale‐17 scores [ Time Frame: the 1 day after the last ECT ]the patients' depression were evaluated with Hamilton Depression Scale with 17 questions after ECT. The scores ranged 0‐68, and <7 were normal, the higher the score means more serious disease.

  2. Montgomery‐Asberg Depression Rating Scale scores [ Time Frame: the 1 day after the last ECT ]the patients' depression were evaluated with Montgomery‐Asberg Depression Rating Scale scores after ECT. The scores ranged 0‐60, and <17 were normal, the higher the score means more serious disease.

Starting date August 1, 2020
Contact information qiuyan_mz@126.com
Notes NCT04399070